Technology News and Research

RSS

RainDance Technologies closes $16.5 million Series E financing round

RainDance Technologies, Inc., an innovative genomics tools company making molecular testing of complex diseases more standardized and readily available, today announced that it has closed a $16.5 million Series E financing round extension. New investors include GE Ventures and Northgate Capital; all existing financial investors also participated in this round of financing.

3 Mar 2014

Microencapsulated drug delivery may soon revolutionize cancer treatment

Invasive and systemic cancer treatment is a necessary evil for many people with the devastating diagnosis. These patients endure therapies with ravaging side effects, including nausea, immune suppression, hair loss and even organ failure, in hopes of eradicating cancerous tissues in the body.

3 Mar 2014

Researchers develop new handheld electronic device that help overcome hand shakes caused by tremor

For people whose hands shake uncontrollably due to a medical condition, just eating can be a frustrating and embarrassing ordeal - enough to keep them from sharing a meal with others.

3 Mar 2014

Study establishes innovative approaches to improve vision of young children with brain tumor

Robert Avery, DO, MSCE, of Children's National Health System and colleagues are establishing innovative approaches with technology and medication to improve the vision of young children who have visual pathway glioma, a type of brain tumor.

3 Mar 2014

Google Glass app helps researchers track spread of diseases around the world

The much-talked-about Google Glass - the eyewear with computer capabilities - could potentially save lives, especially in isolated or far-flung locations, say scientists. They are reporting development of a Google Glass app that takes a picture of a diagnostic test strip and sends the data to computers, which then rapidly beam back a diagnostic report to the user.

3 Mar 2014

PerkinElmer launches Lamina slide scanner for clearer visualization of protein biomarker in tissue

PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced the launch of the Lamina multilabel slide scanner at the USCAP 2014 Annual Meeting.

3 Mar 2014

Researchers identify mutations in gene that can reduce risk of developing type 2 diabetes

An international team led by researchers at the Broad Institute and Massachusetts General Hospital (MGH) has identified mutations in a gene that can reduce the risk of developing type 2 diabetes, even in people who have risk factors such as obesity and old age.

3 Mar 2014

New methodology for rapid detection of antibiotics in blood paves way to drug development, personalized treatment

A new methodology for rapidly measuring the level of antibiotic drug molecules in human blood serum has been developed, paving the way to applications within drug development and personalised medicine.

3 Mar 2014

Xeltis completes enrollment for study of spontaneous tissue growth technology

Xeltis, a privately held medical device company dedicated to transforming standards of care in heart valve replacement and vascular surgery, has announced that it has finished enrollment in a five-patient feasibility study of implantable products intended to enable for the first time the spontaneous growth of natural, healthy heart valves and vessels. With its proprietary technology, the company has pioneered an entirely new therapeutic category called Endogenous Tissue Growth, or ETG, in which surgeons use unique implants designed to allow the body to repair itself by growing natural, healthy tissue.

28 Feb 2014

Abingworth announces final closing of £225M ($375M) fund

Abingworth, the international investment group dedicated to life sciences and healthcare, today announced the final closing of its £225m ($375m) fund, Abingworth Bioventures VI (ABV VI). ABV VI, Abingworth's 10th life sciences fund, exceeded its target of £200 million and invests in life sciences and healthcare both in Europe and the US.

28 Feb 2014

Yangon General Hospital first to install Varian technology for cancer treatment

Yangon General Hospital has become the first clinical site in Myanmar to install new technology from Varian Medical Systems (NYSE: VAR) for treating cancer with radiotherapy.

28 Feb 2014

Cedars-Sinai neurosurgeon successfully performs CSF repair surgery on patient

When Elizabeth "Beth" Johnson stood up from working at her computer Oct. 28, she noticed "a kind of funny feeling" in the back of her neck. By Nov. 2, the sensation had become an excruciating headache that came on whenever she tried to stand or sit upright.

28 Feb 2014

Online insurance shoppers may soon turn to third-party registration sites

The Washington Post reports that as officials work toward the final enrollment season push, the administration is turning to some private entrepreneurs to help sign up people. Also, the Los Angeles Times examines how many young people are signing up.

28 Feb 2014

FSU researchers study smart technology that can search for autism, communication delays in infants

Someday your doctor may be able to examine your infant, notice a telltale physical characteristic and say, "Your child has autism — but we've caught it early, so don't worry."

28 Feb 2014

UH scientists working to develop next generation of prostate cancer therapies

A University of Houston scientist and his team are working to develop the next generation of prostate cancer therapies, which are targeted at metabolism.

27 Feb 2014

Covidien closes acquisition of Given Imaging

Covidien plc today announced that it has closed its acquisition of Given Imaging Ltd., providing the company additional scale and scope to serve a significant medical specialty, the multibillion dollar global gastrointestinal (GI) market.

27 Feb 2014

Sarepta Therapeutics reports non-GAAP net loss of $29.1 million for Q4 2013

Sarepta Therapeutics, Inc., a developer of innovative RNA-based therapeutics, today reported financial results for the three months and year ended December 31, 2013, and provided an update of recent corporate developments.

27 Feb 2014

Adocia reports positive preliminary results for first clinical trial of BioChaperone Combo

Adocia announces today positive preliminary results for the first clinical trial on an innovative formulation combining insulin analog Glargine (Lantus, Sanofi), the gold standard basal insulin, with a rapid-acting insulin analog, Lispro (Humalog, Eli Lilly) using Adocia's BioChaperone technology.

27 Feb 2014

Researchers launch new programme to remotely monitor patients undergoing chemotherapy

Researchers from the University of Surrey have today launched a new programme of research called eSMART (Electronic Symptom Management using ASyMS Remote Technology), that uses mobile phone technology to remotely monitor patients who are undergoing chemotherapy to treat breast, bowel and blood cancers.

27 Feb 2014

Cedars-Sinai researchers develop unique imaging device to "light up" malignant brain tumors

Researchers at the Cedars-Sinai Maxine Dunitz Neurosurgical Institute and Department of Neurosurgery have developed a unique, compact, relatively inexpensive imaging device to "light up" malignant brain tumors and other cancers.

27 Feb 2014

Technology News and Research

RainDance Technologies closes $16.5 million Series E financing round

Microencapsulated drug delivery may soon revolutionize cancer treatment

Researchers develop new handheld electronic device that help overcome hand shakes caused by tremor

Study establishes innovative approaches to improve vision of young children with brain tumor

Google Glass app helps researchers track spread of diseases around the world

PerkinElmer launches Lamina slide scanner for clearer visualization of protein biomarker in tissue

Researchers identify mutations in gene that can reduce risk of developing type 2 diabetes

New methodology for rapid detection of antibiotics in blood paves way to drug development, personalized treatment

Xeltis completes enrollment for study of spontaneous tissue growth technology

Abingworth announces final closing of £225M ($375M) fund

Yangon General Hospital first to install Varian technology for cancer treatment

Cedars-Sinai neurosurgeon successfully performs CSF repair surgery on patient

Online insurance shoppers may soon turn to third-party registration sites

FSU researchers study smart technology that can search for autism, communication delays in infants

UH scientists working to develop next generation of prostate cancer therapies

Covidien closes acquisition of Given Imaging

Sarepta Therapeutics reports non-GAAP net loss of $29.1 million for Q4 2013

Adocia reports positive preliminary results for first clinical trial of BioChaperone Combo

Researchers launch new programme to remotely monitor patients undergoing chemotherapy

Cedars-Sinai researchers develop unique imaging device to "light up" malignant brain tumors

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News